Unknown

Dataset Information

0

Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine.


ABSTRACT: We demonstrated that confronting mice to the Unpredictable Chronic Mild Stress (UCMS) procedure-a validated model of stress-induced depression-results in behavioural alterations and biochemical changes in the kynurenine pathway (KP), suspected to modify the glutamatergic neurotransmission through the imbalance between downstream metabolites such as 3-hydroxykynurenine, quinolinic and kynurenic acids. We showed that daily treatment with the IDO1 inhibitor 1-methyl-D-tryptophan partially rescues UCMS-induced KP alterations as does the antidepressant fluoxetine. More importantly we demonstrated that 1-methyl-D-tryptophan was able to alleviate most of the behavioural changes resulting from UCMS exposure. We also showed that both fluoxetine and 1-methyl-D-tryptophan robustly reduced peripheral levels of proinflammatory cytokines in UCMS mice suggesting that their therapeutic effects might occur through anti-inflammatory processes. KP inhibition might be involved in the positive effects of fluoxetine on mice behaviour and could be a relevant strategy to counteract depressive-like symptoms.

SUBMITTER: Laugeray A 

PROVIDER: S-EPMC5102430 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine.

Laugeray Anthony A   Launay Jean-Marie JM   Callebert Jacques J   Mutlu Oguz O   Guillemin Gilles J GJ   Belzung Catherine C   Barone Pascal R PR  

PloS one 20161109 11


We demonstrated that confronting mice to the Unpredictable Chronic Mild Stress (UCMS) procedure-a validated model of stress-induced depression-results in behavioural alterations and biochemical changes in the kynurenine pathway (KP), suspected to modify the glutamatergic neurotransmission through the imbalance between downstream metabolites such as 3-hydroxykynurenine, quinolinic and kynurenic acids. We showed that daily treatment with the IDO1 inhibitor 1-methyl-D-tryptophan partially rescues U  ...[more]

Similar Datasets

| S-EPMC5524920 | biostudies-literature
| S-EPMC4469692 | biostudies-literature
| S-EPMC6527582 | biostudies-literature
| S-EPMC7892574 | biostudies-literature
| S-EPMC4352870 | biostudies-literature
| S-EPMC10303162 | biostudies-literature
| S-EPMC8891102 | biostudies-literature
| S-EPMC6874551 | biostudies-literature
2021-01-13 | GSE160587 | GEO
| S-EPMC6957452 | biostudies-literature